[Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Fiche publication
Date publication
janvier 2020
Journal
Annales de dermatologie et de venereologie
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DALAC Sophie
Tous les auteurs :
Orion C, Dinulescu M, Dalac-Rat S, Giacchero D, Jouary T, Lebbé C, Leccia MT, Maubec E, Meyer N, Mortier L, Dupuy A,
Lien Pubmed
Résumé
The recent publication of randomized trials investigating the efficacy of adjuvant therapy and completion lymph node dissection at microscopic stage III melanoma calls for a reappraisal of melanoma management from different angles: indications for sentinel lymph node biopsy, indications for completion lymph node dissection in microscopic-stage disease, and adjuvant therapies. Our objective was to evaluate current practices and to question French onco-dermatologists about any changes they envisaged in their practices in the light of recent publications.
Mots clés
Adjuvant therapy, Completion lymph node dissection, Curage ganglionnaire, Enquête nationale, France, Ganglion sentinelle, Melanoma, Mélanome, National survey, Sentinel node biopsy, Traitement adjuvant
Référence
Ann Dermatol Venereol. 2020 Jan;147(1):9-17